- Home
- ONDS vs SRPT Comparison
ONDS vs SRPT Comparison
Compare ONDS & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONDS | SRPT |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | ONDS | SRPT |
|---|---|---|
| Price | $8.54 | $22.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 29 |
| Target Price | $10.00 | ★ $26.23 |
| AVG Volume (30 Days) | ★ 76.5M | 3.0M |
| Earning Date | 11-13-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $24,748,922.00 | ★ $2,413,715,000.00 |
| Revenue This Year | $417.68 | $13.72 |
| Revenue Next Year | $244.11 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 208.40 | 47.15 |
| 52 Week Low | $0.57 | $10.42 |
| 52 Week High | $11.70 | $129.84 |
Technical Indicators
Market Signals| Indicator | ONDS | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 56.53 |
| Support Level | $8.67 | $20.14 |
| Resistance Level | $9.84 | $22.52 |
| Average True Range (ATR) | 0.91 | 1.08 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 47.48 | 71.07 |
Price Performance
Historical ComparisonAbout ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.